GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model

BORIS DOI
Publisher DOI
PubMed ID
39224600
Date of Publication
2024-08-19
Publication Type
Article
Keyword(s)
Toll-like receptor 7
•
breast cancer
•
cancer immunology
•
gasdermin D
•
immunotherapy
Language(s)
en
Contributor(s)
Boersma, Bart
Puddinu, Viola
Huard, Arnaud
Fauteux-Daniel, Sébastien
Wirapati, Pratyaksha
Guedri, Sofia
Tille, Jean-Christophe
McKee, Thomas
Pittet, Mikael
Palmer, Gaby
Additional Credits
Series
Frontiers in Immunology
Publisher
Frontiers Media
ISSN
1664-3224
Access(Rights)
open.access
Show full item